NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of DexCom, Inc.…
Tue, 11 Mar 2025 11:15:08 GMT Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Tue, 11 Mar 2025 10:15:00 GMT Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $95.0 for DexCom over the last 3 months.
Sun, 09 Mar 2025 16:59:00 GMT During the past quarter, major indices, including the S&P 500 and Nasdaq, experienced consecutive weekly declines of over 3%, reflecting general market volatility. In contrast, DexCom shares fell ...
Sun, 09 Mar 2025 01:43:00 GMT Jones Financial Companies Lllp boosted its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 43.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund ...
